CS209618B1 - Method of making-1-methyl-1,2,3,4-tetrahydro-9h-pyrido/3,4-b/indole -1-karboxylate - Google Patents

Method of making-1-methyl-1,2,3,4-tetrahydro-9h-pyrido/3,4-b/indole -1-karboxylate Download PDF

Info

Publication number
CS209618B1
CS209618B1 CS278780A CS278780A CS209618B1 CS 209618 B1 CS209618 B1 CS 209618B1 CS 278780 A CS278780 A CS 278780A CS 278780 A CS278780 A CS 278780A CS 209618 B1 CS209618 B1 CS 209618B1
Authority
CS
Czechoslovakia
Prior art keywords
methyl
pyrido
indole
tetrahydro
formula
Prior art date
Application number
CS278780A
Other languages
Czech (cs)
Inventor
Josef Hajicek
Jan Trojanek
Original Assignee
Josef Hajicek
Jan Trojanek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Josef Hajicek, Jan Trojanek filed Critical Josef Hajicek
Priority to CS278780A priority Critical patent/CS209618B1/en
Publication of CS209618B1 publication Critical patent/CS209618B1/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Metyl-1-metyl-1,2,3,4-tetrahydro-9H- -pyrido(3,4-b)indol-1-karboxylát vzorce I, (I) důležitý meziprodukt syntézy některých léčiv, vzniká transesterifikací tricykliokého aminoesteru obecného vzorce II (II) v němž R značí allyl se 2 až 4 ku, účinkem natriummetoxidu ve metanolu. atomy uhlívroucímMethyl 1-methyl-1,2,3,4-tetrahydro-9H- -pyrido (3,4-b) indole-1-carboxylate of formula I, (AND) an important intermediate in the synthesis of some drugs, arises by transesterification of tricyclic of the amino ester of formula II (II) wherein R is allyl is 2 to 4 sodium methoxide methanol. carbon atoms

Description

* Vynález se týká způsobu výroby metyl-1-metyl-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indol-1-karboxylátu vzorce XThe present invention relates to a process for the preparation of methyl 1-methyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-1-carboxylate of formula X

(I)(AND)

Sloučenina uvedeného vzorce I je známá a je důležitým meziproduktem syntézy léčiv.The compound of formula (I) is known and is an important intermediate in drug synthesis.

Podle literatury (Kuehne Μ. E. a spol.: J. Org. Chem. 44.' 2477 (1979) se tento ester vyrábí tak, že se hydrochlorid tryptaminu kondenzuje za zvýšené teploty s metyl-pyruvátem, nebo se podle alternativního postupu (Hahn G. a spol.: Lieb. Ann. Chem. 520, 107 /1935/) příslušná kyselina kysele esterifikuje metanolem. Zjistili jsme nyní, že lze metylester I také výhodně připravit trans-esterifikací z jiných esterů příslušné matečné kyseliny.According to the literature (Kuehne ΜE. et al., J. Org. Chem. 44. '2477 (1979), this ester is produced by condensing tryptamine hydrochloride with methyl pyruvate at elevated temperature, or by an alternative process ( Hahn, G. et al., Lieb. Ann. Chem., 520, 107 (1935)) acidifies the acid with methanol, and we have now found that the methyl ester I can also be conveniently prepared by trans-esterification from other esters of the corresponding parent acid.

Podstata vynálezu spočívá v tom, že se tricyklický aminoester obecného vzorce II,The principle of the invention is that the tricyclic amino ester of formula II

ve kterém R značí alkyl se 2 až 4 atomy uhlíku, zahřívá s natrium-metoxidem v metanolu.wherein R is C 2 -C 4 alkyl is heated with sodium methoxide in methanol.

Podle vynálezu se postupuje tak, že se k roztoku aminoesteru obecného vzorce XI v metanolu přidá roztok natriummetoxidu a směs se zahřívá k varu.According to the invention, a solution of the amino ester of formula XI in methanol is added with a solution of sodium methoxide and the mixture is heated to boiling.

Podle výhodné formy provedení se použije méně než stechiometrického, s výhodou katalytického množství natrium-metoxidu.According to a preferred embodiment, less than a stoichiometric, preferably catalytic amount of sodium methoxide is used.

Alternativně se transesterifikace může provádět také zahříváním sloučeniny obecného vzorce II s metanolem v přítomnosti minerální kyseliny. Tento postup však poskytuje ester vzorce I v nižším výtěžku.Alternatively, the transesterification can also be carried out by heating the compound of formula II with methanol in the presence of a mineral acid. However, this procedure yields the ester of formula I in a lower yield.

Příklady provedeníExamples

Příklad 1Example 1

K roztoku 3,0 g (11,61 mmol) etyl-1-metyl-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indol-1-karboxylátu (III, R = Hg.CHj) ve 20 ml bezvodého metanolu se přidá roztok 0,023 g (1,0 mmol) sodíku v 10 ml bezvodého metanolu a směs se zahřívá k varu 45 minut, kdy je reakce dle tenkovrstvé chromatografie ukončena. Po ochlazení a přidání 1,5 ml 30% roztoku chloridu amonného se reakční směs odpaří na rotační vakuové odparce k suchu. Zbytek se rozdělí mezi 2 x 35 ml metylenchloridu a 30 ml vody. Spojené organické fáze se promyjí 10 ml vody a po vysušení síranem sodným se odpaří ve vakuu. Odparek se překrystaluje ze směsi benzenu a petroleteru (5:1). Získá se 2,35 g, tj. 82,9 % metyl-1-metyl-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indol-1-karboxylátu (I). Teplota tání leží v rozmezí 135,5 až 139 °C.To a solution of 3.0 g (11.61 mmol) of ethyl 1-methyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-1-carboxylate (III, R = Hg. CH 2) in 20 ml of anhydrous methanol is added a solution of 0.023 g (1.0 mmol) of sodium in 10 ml of anhydrous methanol and the mixture is heated to boiling for 45 minutes when the reaction is complete by thin layer chromatography. After cooling and addition of 1.5 ml of 30% ammonium chloride solution, the reaction mixture is evaporated to dryness on a rotary evaporator. The residue was partitioned between 2 x 35 mL methylene chloride and 30 mL water. The combined organic phases were washed with 10 ml of water and, after drying over sodium sulfate, evaporated in vacuo. The residue was crystallized from benzene / petroleum ether (5: 1). 2.35 g (82.9%) of methyl 1-methyl-1,2,3,4-tetrahydro-9H-pyrido [3,4-b] indole-1-carboxylate (I) are obtained. Melting point: 135.5-139 ° C.

Příklad2Example2

Směs 28,64 g (100 mmol) butyl-1-metyl-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indol-1-karboxylátu (II, R = CH2.CH2.CH2.CH3) a roztoku natrium-metoxidu, připraveného rozpuštěním 0,115 g (5,0 mmol) sodíku ve 200 ml absolutního metanolu, se zahřívá k varu 1,5 h. Po přidání 5 ml 30% roztoku chloridu amonného se reakční směs odpaří ve vakuu vodní vývěvy. Zbytek se rozdělí mezi 2 x 100 ml chloroformu a 100 ml vody. Spojené organické fáze se promyjí 30 ml vody a 2 x 50 ml solanky a odpaří se na rotační vakuové odparce. Odparek se překrysta209618 luje z benzenu. Získá se 18,13 g metyl-1-metyl-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indol-1-karboxylátu (I) s teplotou tání 135 až 138,5 °C. Výtěžek odpovídá 74,2 % teorie.A mixture of 28.64 g (100 mmol) of butyl 1-methyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-1-carboxylate (II, R = CH2.CH2.CH2) CH 3) and a solution of sodium methoxide, prepared by dissolving 0.115 g (5.0 mmol) of sodium in 200 ml of absolute methanol, is heated to boiling for 1.5 hours. After addition of 5 ml of 30% ammonium chloride solution, the reaction mixture is evaporated water pump. The residue was partitioned between 2 x 100 mL chloroform and 100 mL water. The combined organic phases were washed with 30 ml of water and 2 x 50 ml of brine and evaporated on a rotary evaporator. The residue is recrystallized from benzene. 18.13 g of methyl 1-methyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-1-carboxylate (I) are obtained, m.p. 135-138.5 ° C. . Yield 74.2%.

Claims (1)

1. Způsob výroby metyl-1-metyl-1,2,3,4-tetrahydro-9H-pyrido(3,4-b)indol-1-karboxylátu vzorce I (I) vyznačující se tím, že se tricyklický aminoester obecného vzorce II, coon (IX) ve kterém R značí alkyl se 2 až 4 atomy uhlíku, zahřívá v metanolu k varu s katalytickým množstvím natrium metoxidu.A process for the preparation of methyl 1-methyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-1-carboxylate of formula I (I), characterized in that the tricyclic amino ester of the general formula II, a coon (IX) in which R is an alkyl of 2 to 4 carbon atoms, is heated in methanol to boiling with a catalytic amount of sodium methoxide.
CS278780A 1980-04-21 1980-04-21 Method of making-1-methyl-1,2,3,4-tetrahydro-9h-pyrido/3,4-b/indole -1-karboxylate CS209618B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS278780A CS209618B1 (en) 1980-04-21 1980-04-21 Method of making-1-methyl-1,2,3,4-tetrahydro-9h-pyrido/3,4-b/indole -1-karboxylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS278780A CS209618B1 (en) 1980-04-21 1980-04-21 Method of making-1-methyl-1,2,3,4-tetrahydro-9h-pyrido/3,4-b/indole -1-karboxylate

Publications (1)

Publication Number Publication Date
CS209618B1 true CS209618B1 (en) 1981-12-31

Family

ID=5365969

Family Applications (1)

Application Number Title Priority Date Filing Date
CS278780A CS209618B1 (en) 1980-04-21 1980-04-21 Method of making-1-methyl-1,2,3,4-tetrahydro-9h-pyrido/3,4-b/indole -1-karboxylate

Country Status (1)

Country Link
CS (1) CS209618B1 (en)

Similar Documents

Publication Publication Date Title
FI63229C (en) FREQUENCY REFRIGERATION OF ANALYTICAL NETWORK RACEMISKT ELLER DIASTEREOMERA AND OPTICAL ACTIVE 2-TETRAHYDROFURFURYL-5,9 BETA-DIMETHYL-6,7-BENZENORORFAN OCH DERAS SYRAADDITION
CS233665B1 (en) Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene
FI62079B (en) REFRIGERATED FOR EXTRACTION OF A CENTRAL SYSTEM CONNECTED BY N- (METHOXYMETHYLFURYLMETHYL) -6,7-BENZOMORFANER OCH DERAS SYRAADDITIONSSALTER
PL177730B1 (en) Galantamine derivatives, method of obtaining them and pharmaceutical composition
US3714149A (en) Pyridobenzodiazepinones
FI65245C (en) FREQUENCY REQUIREMENT FOR THERAPEUTIC TREATMENT OF THERAPEUTIC ACID 1,2,3,4,6,7-HEXAHYDRO-11BALFAH-BENZO (A) QUINOLIZER FOR SALTER DAERAV
CS219256B2 (en) Method of making the derivative of the imidazothienpyrimidine
US3814765A (en) 8,9-didehydro-10-alkoxy-ergolenes and process of preparation thereof
SU1395143A3 (en) Method of producing derivatives of 1,6-naphthyredene in the form of racemates or enantiomers or acid-additive salts thereof
US4039558A (en) Amino-substituted tetracyclic compounds
SU558644A3 (en) The method of obtaining imidazoles or their salts
CS209618B1 (en) Method of making-1-methyl-1,2,3,4-tetrahydro-9h-pyrido/3,4-b/indole -1-karboxylate
US4956384A (en) 1,4:3,6-dianhydrosorbitol 2-mononitrate and 5-mononitrate esters and pharmaceutical compositions therefrom
SU1428200A3 (en) Method of producing racemic or optically active derivatives of 9-or 11-aminoeburnancarboxylic acid or acid-additive salts thereof
US3657245A (en) Certain 5h 8h-thiazolo(3 2-a)pyrrolo(2 3-d)pyrimidin-5-ones
IE72142B1 (en) Process for preparing ergoline derivatives
US3681355A (en) Ergonarcarnines
HRP20020471A2 (en) Process for the preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo[1,2-a]pyrimidine-3-(n,n-dimethyl-acetamide) and intermediates
OKAWARA et al. Facile Formation of 1, 3-Disubstituted 2, 3, 5, 6-Tetrahydro-2-thioxopyrimidin-4 (1H)-ones and 2-N, 3-Disubstituted 2, 3, 5, 6-Tetrahyro-2-imino-1, 3-thiazin-4-ones from Thioureas and β-Haloacyl Halides
US4500708A (en) Benzothiazine derivatives
US3274212A (en) 1, 3-dialkylprolines
US3772299A (en) P'-alkoxy-ergotamines
FI74956C (en) Process for the preparation of alkyl-4-oxide-5-methyl-pyrazine-2-carboxylic acid.
US3228939A (en) Methyl and i,g-dimethyl-ergoline ii derivatives
US3542799A (en) 4,4a,6,7,12,12b,13,13a-octahydro-1h-pyrido(1,2-a:3,4-b')diindol-3(2h)-ones